Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 6.81 Delayed Data As of 4:00pm ET |  -0.27 / -3.81%Today’s Change | 6.00 Today|||52-Week Range 14.40 | -50.83% Year-to-Date |
Latest ALPN News | Press Releases
No recent news for Alpine Immune Sciences Inc.
Today’s Trading
| Previous close | 7.08 |
| Today’s open | 7.10 |
| Day’s range | 6.79 - 7.18 |
| Volume | 2,109 |
| Average volume (3 months) | 93,937 |
| Market cap | $314.2M |
Data as of 4:00pm ET, 10/07/2022
Growth & Valuation
| Earnings growth (last year) | -47.26% |
| Earnings growth (this year) | +46.72% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +151.13% |
| P/E ratio | NM |
| Price/Sales | 15.05 |
| Price/Book | 1.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALDXAldeyra Therapeutics... | -0.16 | -2.83% |
| WVEWAVE Life Sciences L... | +0.37 | +9.89% |
| ---- | ||
| BTAIBioXcel Therapeutics... | -0.60 | -5.12% |
Data as of 4:00pm ET, 10/07/2022
Financials
| Next reporting date | November 17, 2022 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $23.4M |
| Annual profit (last year) | -$50.3M |
| Net profit margin | -214.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
